|Table of Contents|

Application of carbon nanoparticles in unilateral central lymph node dissection for patient with cN0 papillary thyroid carcinoma

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2017 01
Page:
38-41
Research Field:
Publishing date:

Info

Title:
Application of carbon nanoparticles in unilateral central lymph node dissection for patient with cN0 papillary thyroid carcinoma
Author(s):
Zhang Hua; Wang Minghua; Wang Geng
Department of Endocrine and Vascular Surgery，Taihe Hospital Affiliated to Hubei University of Medicine，Hubei Shiyan 442000，China.
Keywords:
papillary thyroid carcinoma; carbon nanoparticles; central lymph node dissection
PACS:
R736.1
DOI:
10.3969/j.issn.1672-4992.2017.01.010
Abstract:
Objective：To study the value of carbon nanoparticles in unilateral central lymph node dissection for patient with cN0 papillary thyroid carcinoma.Methods：The data of 96 patients with cN0 papillary thyroid carcinoma from July 2014 to June 2015 were analyzed retrospectively(trial group).The control group was the other 98 patients from June 2013 to June 2014.All patients underwent total thyroidectomy plus unilateral central lymph node dissection.Carbon nanoparticles were injected beneath the ture capsule of thyroid gland in trial group.The number of lymph node harvested in surgery，the rate of lymph metastasis were counted.The incidence of postoperative complications including hypocalcemia and recurrent laryngeal nerve injure were compared between the two groups.Results：The number of lymph node harvested in trial group was much more than the control group ［（8.44±2.39） vs (4.26±1.23）］.The rate of lymph metastasis as higher in trial group was much more than the control group （45.9% vs 28.1%）.There was 1 case temporary recurrent laryngeal nerve injure in both group(the injure rate was 1.1%).The incidence of temporary hypocalcemia in experimental group was much low than that in control group （15.3% vs 29.2%）.There were no patients with permanent hypocalcemia nor recurrent laryngeal nerve injure in both group.Conclusion：Application of carbon nanoparticles in central lymph node dissection may harvest more lymph nodes，incease the detected rate of lymph metastasis，protect parathyroid and improve quality of surgery.

References:

［1］Davies L，Welch HG.Increasing incidence of thyroid cancer in the united states，1973-2002［J］.JAMA，2006，295(18)：2164-2167.
［2］David S Cooper.Revised american thyroid association management guidelines for patients with thyroid nodules and differentiated thyroid cancer［J］.Thyroid，2009，19(11)：1167-1214.
［3］Chinese society of endcrinology.Management guidelines for patients with thyroid nodules and differentiated thyroid cancer［J］.Chinese J Clin Oncol，2012，39（17）：1249-1272.［中华医学会内分泌学分会.中国甲状腺结节和分化型甲状腺癌诊治指南［J］.中国肿瘤临床，2012，39（17）：1249-1272.］
［4］Zhang Hua，Wang Minghua，Wang Geng.Medial approach for recurrent laryngeal nerve disscection in thyroid surgery［J］.Chin J General Surg，2011，10(11)：1168-1170.［张华，王明华，王耕.中间入路解剖喉返神经在甲状腺手术中的应用［J］.中国普通外科杂志，2011，10(11)：1168-1170.］
［5］Grebe SK，Hay ID.Thyroid cancer nodal metastases：biologic significance and therapeutic considerations［J］.Surg Oncol Clin N Am，1996，5(1)：43-63.
［6］Scheumann GF，Gimm O，Wegener G，et al.Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer［J］.World J Surg，1994，18(4)：559-567.
［7］Clark OH.Thyroid cancer and lymph node metastases［J］.J Surg Oncol，2011，103(6)：615-618.
［8］Takada H，Kikumori T，Imai T，et al.Patterns of lymph node metastases in papillary thyroid carcinoma：results from consecutive bilateral cervical lymph node dissection［J］.World J Surg，2011，35(7)：1560-1566.
［9］Qubain SW，Nakano S，Baba M，et al.Distribution of lymph node micrometastasis in pN0 well-differentiated thyroid carcinoma［J］.Surgery，2002，131(3)：249-256.
［10］Gimm O，Rath FW，Dralle H.Pattern of lymph node metastases in papillary thyroid carcinoma［J］.Br J Surg，1998，85(2)：252-254.
［11］McHenry CR，Stulberg JJ.Prophylactic central compartment neck dissection for papillary thyroid cancer［J］.Surg Clin North Am，2014，94(3)：529-540.
［12］Sipos JA.Advances in ultrasound for the diagnosis and management of thyroid cancer［J］.Thyroid，2009，19(12)：1363-1372.
［13］Ito Y，Tomoda C，Uruno T，et al.Clinical significance of metastasis to the central compartment from papillary microcarcinoma of the thyroid［J］.World J Surg，2006，30(1)：91-99.
［14］Roh JL，Kim JM，Park CI.Central compartment reoperation for recurrent/persistent differentiated thyroid cancer：patterns of recurrence，morbidity，and prediction of postoperative hypocalcemia［J］.Ann Surg Oncol，2011，18(5)：1312-1318.
［15］Anthony R，Glver Justin，S Gundara，et al.The pros and cons of prophylactic central neck dissection in papillary thyroid carcinoma［J］.Gland Surg，2013，2(4)：196-205.
［16］Ofo E，Thavaraj S.Quantification of lymph nodes in the central compartment of the neck：a cadaveric study［J］.Eur Arch Otorhinolaryngol，2016，273（9）：2273-2778.
［17］Li Hongqiang，Yin Detao.The effect of carbon nanoparticles in central lymph node dissection for patient with papillary thyroid carcinoma［J］.Chin J Endocrine Surg，2015，9（5）：398-400.［李红强，殷德涛.纳米碳悬液在甲状腺乳头状癌中央区淋巴结清扫中的疗效［J］.中华内分泌外科杂志，2015，9（5）：398-400.］
［18］Hagiwara A，Takahashi T，Sawai K，et al.Lymph nodal vital staining with newer carbon particle suspensions compared with India ink：experimental and clinical observations［J］.Lymphology，1992，25(2)：84-89.
［19］Chinese Thyroid Association.Expert consensus on parathyroid preservation in thyroid surgery［J］.Chinese J Practical Surg，2015，35（7）：731-736.［中国医师协会外科医师分会甲状腺外科医师委员会.甲状腺手术中甲状旁腺保护专家共识［J］.中国实用外科杂志，2015，35（7）：731-736.］
［20］Giordano D，Valcavi R，Thompson GB，et al.Complications of central neck dissection in patients with papillary thyroid carcinoma：results of a study on 1087 patients and review of the literature［J］.Thyroid，2012，22(9)：911-917.

Memo

Memo:
十堰市科学技术研究与开发项目计划（编号：2014Y10）
Last Update: 2016-12-01